{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-274871","form_type":"8-K","ticker":"IBRX","cik":"0001326110","company_name":"ImmunityBio, Inc.","filed_at":"2024-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.114806+00:00","generated_at":"2026-05-29T04:38:26.133842+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ImmunityBio prices $100M public offering at $3/sh and restructures $505M Nant Capital note","bullets":["Public offering of 33.3M shares at $3/sh for gross proceeds ~$100M; net to company ~$93.1M from firm shares.","Underwriters have 30-day option to purchase additional 5M shares at $3/sh; potential net proceeds $107.2M.","Concurrent debt restructuring: Nant Capital notes consolidated into $505M note due Dec 2027, interest SOFR+8%, convertible at $5.427/sh.","Limited consent from Oberland Capital (RIPA) obtained for the debt restructuring.","Net proceeds intended for ANKTIVA commercialization, BCG-naïve NMIBC and NSCLC trials, R&D, working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-274871","json":"https://secwatch.observer/filing/0001193125-24-274871.json","markdown":"https://secwatch.observer/filing/0001193125-24-274871.md","text":"https://secwatch.observer/filing/0001193125-24-274871.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326110/000119312524274871/0001193125-24-274871-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326110/000119312524274871/d875134d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:38:26.133842+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}